# ‘Biggest leap forward in decades’: Daily pill makes deadly cancer tumours disappear in major trial

- URL: https://talkfuse.com/story/biggest-leap-forward-in-decades-daily-pill-makes-deadly-cancer-tumours-disappear-in-major-trial/
- Published: 2026-11-20T09:51:38+00:00
- Updated: 2026-11-20T10:23:40+00:00
- Original publisher: GB News (publisher lean: Right)
- Original article: https://www.gbnews.com/health/pancreatic-cancer-breakthrough-daily-pill
- Topics: Europe, Health, Medicine, UK, World

## Key points

- Daraxonrasib plus chemotherapy shrank or eliminated tumours in 60.7 per cent of trial patients.
- About one in 12 patients had tumours become undetectable.
- Larger trials and longer follow-up are needed before NHS use can be assessed.

## Summary

In an early trial, the daily pill daraxonrasib, given with chemotherapy, shrank or made tumours disappear in many people with advanced pancreatic cancer. The findings have raised hopes for a disease that is often difficult to treat, but researchers say further trials are needed before the drug could be considered for NHS use.

The phase one/two study involved 61 patients whose cancer had spread beyond the pancreas: tumours shrank or vanished in 60.7 per cent, and progression was halted in 90.2 per cent. After a year, 76.6 per cent were alive, compared with an estimated 40 to 45 per cent for chemotherapy alone; tumours became undetectable in about one in 12. Daraxonrasib targets mutated KRAS, found in more than nine in 10 pancreatic tumours, but longer follow-up is needed because cancers can develop resistance.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
